Inhibit osteoclast activation and differentiation, reduce bone resorption Block osteoclast differentiation signal RANKL/RANK/OPG pathway: AOD 9604 downregulates the expression of RANKL (a key factor in osteoclast differentiation) and upregulates the expression of OPG (a RANKL antagonist), reducing the RANKL/OPG ratio by 50-60% and blocking the differentiation of osteoclast precursors into mature osteoclasts
This is no longer limited to situations where triple therapy is ineffective, not tolerated, or contraindicated
The agency advises consumers to: Only use medicines that have been prescribed by a registered healthcare professional and dispensed by a regulated pharmacy
Phase 2 data showed improvements in fasting glucose, HbA1c, insulin sensitivity, triglycerides, waist circumference, and liver fat content measured by MRI
Peptides like Retatrutide require manual preparation, making the calculator essential